Eugene Ruzagira

1.8k total citations
54 papers, 752 citations indexed

About

Eugene Ruzagira is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Eugene Ruzagira has authored 54 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 21 papers in Epidemiology and 16 papers in Virology. Recurrent topics in Eugene Ruzagira's work include HIV/AIDS Research and Interventions (34 papers), HIV, Drug Use, Sexual Risk (19 papers) and HIV Research and Treatment (16 papers). Eugene Ruzagira is often cited by papers focused on HIV/AIDS Research and Interventions (34 papers), HIV, Drug Use, Sexual Risk (19 papers) and HIV Research and Treatment (16 papers). Eugene Ruzagira collaborates with scholars based in Uganda, United Kingdom and United States. Eugene Ruzagira's co-authors include Anatoli Kamali, Heiner Grosskurth, Samuel Biraro, Ubaldo Bahemuka, Matt A. Price, Joseph B. Babigumira, Carole Fogg, James Kiguli, Francis Bajunirwe and Francesco Grandesso and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Eugene Ruzagira

49 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugene Ruzagira Uganda 15 430 258 247 181 135 54 752
Jaco Homsy Uganda 17 643 1.5× 302 1.2× 270 1.1× 398 2.2× 138 1.0× 38 1.1k
Narongrid Sirisopana Thailand 14 416 1.0× 114 0.4× 194 0.8× 101 0.6× 256 1.9× 23 626
David Hoos United States 13 510 1.2× 85 0.3× 292 1.2× 191 1.1× 150 1.1× 26 662
Nicole Fraser‐Hurt United States 18 410 1.0× 281 1.1× 328 1.3× 238 1.3× 65 0.5× 52 873
Abraham Katana Kenya 17 372 0.9× 211 0.8× 163 0.7× 236 1.3× 50 0.4× 37 711
Julia Mwesigwa Gambia 21 305 0.7× 507 2.0× 107 0.4× 88 0.5× 102 0.8× 31 870
Amha Kebede Ethiopia 20 404 0.9× 301 1.2× 160 0.6× 49 0.3× 23 0.2× 55 870
Baltazar Candrinho Mozambique 18 239 0.6× 531 2.1× 94 0.4× 127 0.7× 49 0.4× 57 842
John Rubaihayo Uganda 14 361 0.8× 139 0.5× 194 0.8× 221 1.2× 50 0.4× 29 604
Hypolite Muhindo Mavoko Democratic Republic of the Congo 14 219 0.5× 276 1.1× 67 0.3× 46 0.3× 20 0.1× 50 601

Countries citing papers authored by Eugene Ruzagira

Since Specialization
Citations

This map shows the geographic impact of Eugene Ruzagira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Ruzagira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Ruzagira more than expected).

Fields of papers citing papers by Eugene Ruzagira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Ruzagira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Ruzagira. The network helps show where Eugene Ruzagira may publish in the future.

Co-authorship network of co-authors of Eugene Ruzagira

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene Ruzagira. A scholar is included among the top collaborators of Eugene Ruzagira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene Ruzagira. Eugene Ruzagira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Kitonsa, Jonathan, Onesmus Kamacooko, Eugene Ruzagira, et al.. (2023). A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences. Human Vaccines & Immunotherapeutics. 19(2). 2240690–2240690. 3 indexed citations
5.
Okello, Elialilia S., Philip Ayieko, Zachary Kwena, et al.. (2023). Acceptability and applicability of biometric iris scanning for the identification and follow up of highly mobile research participants living in fishing communities along the shores of Lake Victoria in Kenya, Tanzania, and Uganda. International Journal of Medical Informatics. 172. 105018–105018. 1 indexed citations
6.
Hansen, Christian Holm, et al.. (2023). Developing HIV risk prediction tools in four African settings. Tropical Medicine & International Health. 28(9). 720–730. 1 indexed citations
7.
Nakamanya, Sarah, et al.. (2022). Assessing acceptability of pre-exposure prophylaxis (PrEP) among participants in an HIV vaccine preparedness study in southwestern Uganda. PLoS ONE. 17(7). e0271104–e0271104. 3 indexed citations
8.
Whitworth, Hilary, Jonathan Kitonsa, Brian Greenwood, et al.. (2022). COVID-19 Vaccine Acceptability Among Healthcare Facility Workers in Sierra Leone, the Democratic Republic of Congo and Uganda: A Multi-Centre Cross-Sectional Survey. International Journal of Public Health. 67. 1605113–1605113. 3 indexed citations
9.
Kitonsa, Jonathan, Onesmus Kamacooko, Ubaldo Bahemuka, et al.. (2021). Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda. PLoS ONE. 16(5). e0251992–e0251992. 19 indexed citations
10.
Bahemuka, Ubaldo, Andrew Abaasa, Eugene Ruzagira, et al.. (2019). Retention of adults from fishing communities in an HIV vaccine preparedness study in Masaka, Uganda. PLoS ONE. 14(1). e0198460–e0198460. 11 indexed citations
11.
12.
Mutua, Gaudensia, Juliet Mpendo, William Kilembe, et al.. (2014). Major Negative Social Impacts Are Rare in Phase 1 HIV Vaccine Trials in Africa. AIDS Research and Human Retroviruses. 30(S1). A190–A191. 2 indexed citations
13.
Abaasa, Andrew, Gershim Asiki, Ubaldo Bahemuka, et al.. (2014). The “Worried Well” Among Clients Attending HIV/AIDS Counselling and Testing Services at a Clinical Research Centre in SW Uganda. AIDS Research and Human Retroviruses. 30(S1). A113–A114. 1 indexed citations
14.
Asiki, Gershim, Ubaldo Bahemuka, Freddie Kibengo, et al.. (2014). Participation of Individuals from Fishing Communities in a Simulated Vaccine Efficacy Trial in Preparation for Future HIV Prevention Work. AIDS Research and Human Retroviruses. 30(S1). A163–A163. 1 indexed citations
15.
Asiki, Gershim, Andrew Abaasa, Eugene Ruzagira, et al.. (2013). Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda. Vaccine. 31(44). 5055–5061. 31 indexed citations
16.
Biraro, Samuel, Eugene Ruzagira, Anatoli Kamali, et al.. (2013). HIV-1 Transmission within Marriage in Rural Uganda: A Longitudinal Study. PLoS ONE. 8(2). e55060–e55060. 33 indexed citations
18.
Ruzagira, Eugene, Agnes Bwanika Naggirinya, Ubaldo Bahemuka, et al.. (2011). HIV Incidence and Risk Factors for Acquisition in HIV Discordant Couples in Masaka, Uganda: An HIV Vaccine Preparedness Study. PLoS ONE. 6(8). e24037–e24037. 40 indexed citations
19.
Anzala, Omu, Julia Sanders, A. Kamali, et al.. (2009). Sensitivity And Specificity Of Hiv Rapid Tests Used For Research And Voluntary Counselling And Testing. East African Medical Journal. 85(10). 500–4. 14 indexed citations
20.
Checchi, Francesco, Patrice Piola, Carole Fogg, et al.. (2006). Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda. Malaria Journal. 5(1). 59–59. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026